Untitled

346 REVERSIBLE DISORDERS OF BRAIN DEVELOPMENTschizophrenia: Toward intervention and prevention. Canadian Journal of Psychiatry,47(6), 518–526.Vieta, E., & Colom, F. (2004). Psychological interventions in bipolar disorder: Fromwishful thinking to an evidence-based approach. ACTA Psychiatrica Scandinavica.Supplementum.(422), 34–38.Wals, M., Hillegers, M. H., Reichart, C. G., Ormel, J., Nolen, W. A., & Verhulst, F. C.(2001). Prevalence of psychopathology in children of a bipolar parent. Journal of theAmerican Academy of Child and Adolescent Psychiatry, 40(9), 1094–1102.Wei, Z., Bai, O., Richardson, J. S., Mousseau, D. D., & Li, X. M. (2003). Olanzapineprotects PC12 cells from oxidative stress induced by hydrogen peroxide. Journal ofNeuroscience Research, 73(3), 364–368.Wozniak, J., Biederman, J., Kiely, K., Ablon, J. S., Faraone, S. V., Mundy, E., et al. (1995).Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referredchildren. Journal of the American Academy of Child and Adolescent Psychiatry,34(7), 867–876.Yang, Y., Li, Q., Wang, C. X., Jeerakathil, T., & Shuaib, A. (2000). Dose-dependentneuroprotection with tiagabine in a focal cerebral ischemia model in rat. Neuroreport,11(10), 2307–2311.Yang, Y., Shuaib, A., Li, Q., & Siddiqui, M. M. (1998). Neuroprotection by delayed administrationof topiramate in a rat model of middle cerebral artery embolization. BrainResearch, 804(2), 169–176.Yurgelun-Todd, D. A., Gruber, S. A., Kanayama, G., Killgore, W. D., Baird, A. A., &Young, A. D. (2000). fMRI during affect discrimination in bipolar affective disorder.Bipolar Disorders, 2(3 t. 2), 237–248.